PUBLISHER: The Business Research Company | PRODUCT CODE: 1945271
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945271
A heart pump device is a mechanical support device designed to assist in pumping blood from the heart chambers to the rest of the body, temporarily aiding the heart's pumping action.
Heart pump devices come in two main types including implantable heart pump devices and extracorporeal heart pump devices. Implantable heart pump devices are mechanical pumps surgically implanted in the chest to assist a weakened heart in pumping blood. These devices serve various therapeutic purposes, including bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and others. Heart pump devices find applications in diverse healthcare settings, including hospitals, ambulatory surgical centers, specialty clinics, and more.
Tariffs are impacting the heart pump devices market by increasing costs of imported medical-grade metals, electronic controllers, sensors, and precision components used in implantable and extracorporeal pump systems. North America and Europe are most affected due to reliance on imported high-complexity components, while Asia-Pacific faces higher manufacturing costs for export-oriented devices. These tariffs are increasing device prices and limiting accessibility in some healthcare systems. However, they are also encouraging localized manufacturing, regional component sourcing, and innovation in cost-efficient heart pump technologies.
The heart pump devices market research report is one of a series of new reports from The Business Research Company that provides heart pump devices market statistics, including heart pump devices industry global market size, regional shares, competitors with a heart pump devices market share, detailed heart pump devices market segments, market trends and opportunities, and any further data you may need to thrive in the heart pump devices industry. This heart pump devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The heart pump devices market size has grown rapidly in recent years. It will grow from $4.48 billion in 2025 to $5.32 billion in 2026 at a compound annual growth rate (CAGR) of 19.0%. The growth in the historic period can be attributed to rising incidence of heart failure, expansion of cardiac surgery programs, advancements in mechanical pump design, increasing transplant wait times, growing use of extracorporeal support systems.
The heart pump devices market size is expected to see rapid growth in the next few years. It will grow to $10.37 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to increasing demand for long-term circulatory support, rising adoption of destination therapy devices, expansion of minimally invasive cardiac procedures, growing integration of smart monitoring technologies, increasing investments in advanced cardiac care. Major trends in the forecast period include increasing use of advanced ventricular assist devices, rising adoption of temporary mechanical circulatory support, growing focus on miniaturized implantable pumps, expansion of bridge-to-transplant therapies, enhanced monitoring of hemodynamic performance.
The rising prevalence of cardiovascular disorders is anticipated to drive the growth of the heart pump devices market. Cardiovascular disorders encompass conditions affecting the heart and blood vessels. As the incidence of cardiovascular diseases rises, there will be a greater need for advanced diagnostics and treatments, including heart pump devices. These devices are essential for pumping blood from the lower left chamber of the heart, especially during high-risk protected percutaneous coronary interventions, thereby increasing market demand. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK-based government body, revealed that in 2023, over 1,862,500 individuals (3%) in England had a GP diagnosis of coronary heart disease (CHD). Notably, the proportion of individuals diagnosed with CHD has declined since the financial year ending in 2010. Thus, the increasing prevalence of cardiovascular disorders is fueling the growth of the heart pump devices market.
Major companies operating in the heart pump devices market are developing extracorporeal membrane oxygenation (ECMO) systems to provide advanced life support for patients with severe heart and lung conditions. Extracorporeal membrane oxygenation (ECMO) systems refer to advanced life support machines used to provide prolonged cardiac and respiratory support for patients whose heart and lungs are unable to function properly. For instance, in September 2024, Medtronic plc, an Ireland-based medical device company, launched VitalFlow system, an innovative extracorporeal membrane oxygenation (ECMO) solution designed to provide circulatory support for patients with severe heart or lung failure. The VitalFlow system functions as a heart pump by using a pump and oxygenator to take over the work of the heart and lungs. This is crucial for patients experiencing life-threatening conditions, allowing their organs to rest and heal.
In May 2023, BioForum Inc., a United States-based healthcare technology company, entered into a partnership with Abiomed Inc. to strengthen cardiovascular care solutions. Through this collaboration, BioForum Inc. aims to deliver streamlined and high-quality clinical trial data management and advanced analytics services to Abiomed, thereby improving operational efficiency, accelerating regulatory submission timelines, and supporting the generation of robust real-world evidence. Abiomed Inc. is a United States-based healthcare technology company specializing in the development and manufacture of percutaneous and surgical heart pump systems designed to enhance patient outcomes in heart failure and other circulatory disorders.
Major companies operating in the heart pump devices market are Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova plc, SynCardia Systems Inc, CARMAT SA, Jarvik Heart Inc, BiVACOR Inc, CorWave SA, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Nipro Corporation, Eurosets Srl, CardioBridge GmbH, Hemovent GmbH, Evaheart Inc, Calon Cardio-Technology Ltd, Lepu Medical Technology Co Ltd, NewHeart Technologies Inc
North America was the largest region in the heart pump devices market share in 2025. The regions covered in the heart pump devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the heart pump devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The heart pump devices market consists of sales of pacemakers, biventricular devices, cardioverter defibrillators, and mechanical assist devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Heart Pump Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses heart pump devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for heart pump devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart pump devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.